Commissioners need to ensure that resources are used and invested effectively. A commissioner will only purchase a new diagnostic if there is evidence that the test benefits patients, is affordable and provides value for money.
Health economic studies help to inform these decisions. These studies develop mathematical models to predict the net costs and net benefits from developing, producing and using a test. This involves assessing the whole patient journey and the final outcomes.
We have expertise in health economics. Look at the work packages we offer in this area by clicking on the sections below.
We can perform early economic modelling to help focus future product and evidence development and inform pricing strategies.
We can measure the cost of adopting the new diagnostic and predict whether it will provide value for money.
We can examine the potential impact of purchasing the new diagnostic on the budget of the local or national healthcare provider.
